Amarin v. FDA

After the Food and Drug Administration denied its application to market one of its drugs for an additional use, drug manufacturer Amarin Pharma, Inc. filed suit against the FDA challenging the restrictions imposed by the Food, Drug, and Cosmetic and the FDA on marketing drugs for unapproved uses. Amarin moved for a preliminary injunction. Public Citizen filed an amicus memorandum in support of the FDA and in opposition to the motion. On August 7, 2015, however, the district court granted the company’s motion for a preliminary injunction. The parties then settled the case.